
    
      To healthy subjects of fifty-two (52), following treatments are administered dosing in each
      period and wash-out period is a minimum of 7 days. Reference drug: D935 Test drug: CKD-385
      Pharmacokinetic blood samples are collected up to 48 hrs. The pharmacokinetic characteristics
      and safety are assessed.
    
  